ADVANCED LUNG CARCINOMA
Clinical trials for ADVANCED LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer combo trial halted early – what we know
Disease control TerminatedThis study tested a new drug (TQB3616) combined with another targeted therapy (anlotinib) or standard chemotherapy for people with advanced lung cancer. The goal was to see if the combination could shrink tumors or slow the disease. Only 21 people took part before the study was s…
Matched conditions: ADVANCED LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Experimental cancer combo trial halted early
Disease control TerminatedThis study tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise radiation for people with advanced solid tumors that had spread. The goal was to see if this approach could help control the cancer and check for side effects. Only 13 people took p…
Matched conditions: ADVANCED LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC